This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2008 Apr 3;358(14):1504-7.

doi: 10.1056/NEJMe0801608. Epub 2008 Mar 30.

Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?

B Greg Brown, Allen J Taylor

PMID: 18376002
DOI: 10.1056/NEJMe0801608

Editorial

Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?

B Greg Brown et al. N Engl J Med. 2008.

. 2008 Apr 3;358(14):1504-7.

doi: 10.1056/NEJMe0801608. Epub 2008 Mar 30.

Authors

B Greg Brown, Allen J Taylor

PMID: 18376002
DOI: 10.1056/NEJMe0801608

No abstract available

PubMed Disclaimer

Comment in

Cholesterol lowering and ezetimibe.
Drazen JM, Jarcho JA, Morrissey S, Curfman GD. Drazen JM, et al. N Engl J Med. 2008 Apr 3;358(14):1507-8. doi: 10.1056/NEJMe0801842. Epub 2008 Mar 30. N Engl J Med. 2008. PMID: 18376001 No abstract available.
Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Connor WE. Connor WE. N Engl J Med. 2008 Jul 31;359(5):530; author reply 532-3. N Engl J Med. 2008. PMID: 18677797 No abstract available.
Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Blake JA. Blake JA. N Engl J Med. 2008 Jul 31;359(5):531; author reply 532-3. N Engl J Med. 2008. PMID: 18677798 No abstract available.
Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Davis HR Jr, Murgolo NJ, Graziano MP. Davis HR Jr, et al. N Engl J Med. 2008 Jul 31;359(5):531; author reply 532-3. N Engl J Med. 2008. PMID: 18677799 No abstract available.
Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Kaye T. Kaye T. N Engl J Med. 2008 Jul 31;359(5):531-2; author reply 532-3. N Engl J Med. 2008. PMID: 18677800 No abstract available.

Comment on

Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de Groot E; ENHANCE Investigators. Kastelein JJ, et al. N Engl J Med. 2008 Apr 3;358(14):1431-43. doi: 10.1056/NEJMoa0800742. Epub 2008 Mar 30. N Engl J Med. 2008. PMID: 18376000 Clinical Trial.

Similar articles

Cholesterol lowering and ezetimibe.
Drazen JM, Jarcho JA, Morrissey S, Curfman GD. Drazen JM, et al. N Engl J Med. 2008 Apr 3;358(14):1507-8. doi: 10.1056/NEJMe0801842. Epub 2008 Mar 30. N Engl J Med. 2008. PMID: 18376001 No abstract available.
Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Connor WE. Connor WE. N Engl J Med. 2008 Jul 31;359(5):530; author reply 532-3. N Engl J Med. 2008. PMID: 18677797 No abstract available.
Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Steinberg D. Steinberg D. N Engl J Med. 2008 Jul 31;359(5):529; author reply 532. doi: 10.1056/NEJMc080981. N Engl J Med. 2008. PMID: 18669434 No abstract available.
Cholesterol absorption inhibitors in the treatment of hyperlipidemia: clinical outcomes in large clinical trials.
Kesäniemi A. Kesäniemi A. Fundam Clin Pharmacol. 2007 Nov;21 Suppl 2:29-30. doi: 10.1111/j.1472-8206.2007.00536.x. Fundam Clin Pharmacol. 2007. PMID: 18001318 Review.
["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].
Olsson AG, Nilsson PM. Olsson AG, et al. Lakartidningen. 2009 Mar 18-24;106(12):854-7. Lakartidningen. 2009. PMID: 19452786 Review. Swedish. No abstract available.

See all similar articles

Cited by

The Effect of Age and Comorbidities on the Association Between the Medicare STAR Oral Antihyperglycemic Adherence Metric and Glycemic Control.
Nichols GA, Raebel MA, Dyer W, Schmittdiel JA. Nichols GA, et al. J Manag Care Spec Pharm. 2018 Sep;24(9):856-861. doi: 10.18553/jmcp.2018.24.9.856. J Manag Care Spec Pharm. 2018. PMID: 30156449 Free PMC article.
Beyond Statins: Emerging Evidence for HDL-Increasing Therapies and Diet in Treating Cardiovascular Disease.
Farrer S. Farrer S. Adv Prev Med. 2018 Jul 9;2018:6024747. doi: 10.1155/2018/6024747. eCollection 2018. Adv Prev Med. 2018. PMID: 30112217 Free PMC article. Review.
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.
Kones R, Rumana U. Kones R, et al. Drugs. 2015 Jul;75(11):1201-28. doi: 10.1007/s40265-015-0429-3. Drugs. 2015. PMID: 26169307 Review.
Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe.
Schwab P, Louder A, Li Y, Mallick R, Bays H. Schwab P, et al. Drugs Aging. 2014 Sep;31(9):683-94. doi: 10.1007/s40266-014-0200-6. Drugs Aging. 2014. PMID: 25091271
Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010.
Ross JS, Frazee SG, Garavaglia SB, Levin R, Novshadian H, Jackevicius CA, Stettin G, Krumholz HM. Ross JS, et al. JAMA Intern Med. 2014 Sep;174(9):1486-93. doi: 10.1001/jamainternmed.2014.3404. JAMA Intern Med. 2014. PMID: 25070672 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

HL-081616/HL/NHLBI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information